Is ABBV a good stock to buy? We came across a bullish thesis on AbbVie Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on ABBV. AbbVie Inc.'s share was trading at $225.42 as of June 9th. ABBV’s trailing and forward P/E were 110.50 and 15.82 respectively according to Yahoo Finance.
[caption id="attachment_575382" align="aligncenter" width="750"]AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.